For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve.

The Wistar Institute, a nonprofit dedicated to biomedical research, is investing $24 million to advance its efforts to identify a cure for HIV. Part of the goal in creating a center at a second ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

HIV is preventable, yet new diagnoses continue in AZ at higher-than-average rates. Could a new, twice-yearly shot called ...

What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best option for them?

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

You may have heard about Descovy (des-ko'-vee), a medicine approved by the FDA in 2015. Descovy is approved to treat HIV. It can also help prevent people from getting HIV through sex. People with HIV ...

HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...